Search

Li X Mei

from San Francisco, CA
Age ~72
Get Report
Also known as:
Li C Lei, Li Qin Lin, Qin Lin Li
Phone and address:
1010 Post St, San Francisco, CA 94109
(415) 346-3288
Related to:
Xing Si MeiChunhua Qi, 54Guang Liang Chen, 82Lan Mei Feng, 70Yunkai K Qi, 64Mei Yanhong, 54Pei X Cai
Connected to:
Andrew W Mei, 79Bing C Mei, 46Bruna E Mei, 31Danielle N Mei, 40Diana L Mei, 66Douglas Mei, 45Gwendolen Y Mei, 53Helena H Mei, 61Jianmin Mei, 58Jorge A Mei, 51

Li Mei Phones & Addresses

  • 1010 Post St, San Francisco, CA 94109 (415) 346-3288
  • 367 Post St, San Francisco, CA 94108

Professional Records

License Records

Li Xian Mei

License #:
RPH05056 - Active
Category:
Pharmacy
Issued Date:
Sep 1, 2011
Expiration Date:
Jun 30, 2017
Type:
Pharmacist

Resumes

Resumes

Li Mei Photo 1

Research Scientist

View page
Location:
South San Francisco, CA
Industry:
Biotechnology
Work:
Amphivena Therapeutics Inc.
Research Scientist
Cytomx Therapeutics
Associate Scientist
Pfizer 2007 - Oct 2013
Scientist
Education:
High School
University of California, Los Angeles
Bachelors, Bachelor of Science, Biochemistry
Skills:
Protein Engineering
Drug Discovery
Molecular Biology
Monoclonal Antibodies
Biochemistry
Li Mei Photo 2

General Manager Tax Reporting

View page
Location:
886 Millerway Dr, Fenton, MI 48430
Industry:
Computer Software
Work:
Microsoft
General Manager Tax Reporting
Netapp 2011 - Oct 2017
Senior Director, Taxes at Netapp
Verisign 2009 - 2011
Tax Director
Yahoo 2005 - 2009
Tax Director
Jdsu 2000 - 2005
Tax Manager
Education:
San Jose State University
Golden Gate University
Skills:
Tax
Sarbanes Oxley Act
Due Diligence
Financial Reporting
Sec Filings
Tax Accounting
International Tax
Accounting
Internal Controls
Revenue Recognition
Us Gaap
Li Mei Photo 3

Li Mei

View page
Li Mei Photo 4

Li Mei

View page
Li Mei Photo 5

Hskp

View page
Work:
Tdhc
Hskp
Li Mei Photo 6

Hskp At Tdhc

View page
Position:
HSKP at TDHC
Location:
United States
Industry:
Gambling & Casinos
Work:
TDHC
HSKP

Business Records

Name / Title
Company / Classification
Phones & Addresses
Li Mei
Principal
Mei Li
Commercial Nonphysical Research
2533 Irving St, San Francisco, CA 94122

Publications

Us Patents

Antibodies, Activatable Antibodies, Bispecific Antibodies, And Bispecific Activatable Antibodies And Methods Of Use Thereof

View page
US Patent:
20210324088, Oct 21, 2021
Filed:
May 2, 2019
Appl. No.:
17/052088
Inventors:
- South San Francisco CA, US
Ellaine Anne Mariano FOX - South San Francisco CA, US
Li MEI - South San Francisco CA, US
Assignee:
CYTOMX THERAPEUTICS, INC. - South San Francisco CA
International Classification:
C07K 16/28
A61K 39/395
A61P 35/00
Abstract:
Provided herein antibodies, activatable antibodies (AAs), bispecific antibodies, and bispecific activatable antibodies (BAAs). Also provided herein are methods of making and methods of use of these antibodies, AAs, bispecific antibodies, and BAAs.

Anti-Pdl1 Antibodies, Activatable Anti-Pdl1 Antibodies, And Methods Of Use Thereof

View page
US Patent:
20200231677, Jul 23, 2020
Filed:
May 31, 2019
Appl. No.:
16/428708
Inventors:
- South San Francisco CA, US
Li Mei - San Francisco CA, US
Stephen James Moore - Danville CA, US
Margaret T.L. Nguyen - San Francisco CA, US
Daniel Robert Hostetter - Palto Alto CA, US
Olga Vasiljeva - Fremont CA, US
Jason Gary Sagert - Cambridge MA, US
Jonathan Alexander Terrett - Cambridge MA, US
International Classification:
C07K 16/28
A61K 49/00
A61K 39/395
Abstract:
The invention relates generally to antibodies that bind programmed death ligand 1 (PDL1), activatable antibodies that specifically bind to PDL1 and methods of making and using these anti-PDL1 antibodies and anti-PDL1 activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.

Anti-Pdl1 Antibodies, Activatable Anti-Pdl1 Antibodies, And Methods Of Use Thereof

View page
US Patent:
20190382493, Dec 19, 2019
Filed:
May 31, 2019
Appl. No.:
16/428767
Inventors:
- San Francisco CA, US
Li Mei - San Francisco CA, US
Stephen James Moore - Danville CA, US
Margaret T.L. Nguyen - San Jose CA, US
Daniel Robert Hostetter - Palto Alto CA, US
Olga Vasiljeva - Cupertino CA, US
Jason Gary Sagert - San Mateo CA, US
Jonathan Alexander Terrett - Cupertino CA, US
International Classification:
C07K 16/28
A61K 49/00
A61K 39/395
Abstract:
The invention relates generally to antibodies that bind programmed death ligand 1 (PDL1), activatable antibodies that specifically bind to PDL1 and methods of making and using these anti-PDL1 antibodies and anti-PDL1 activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.

Anti-Pdl1 Antibodies, Activatable Anti-Pdl1 Antibodies, And Methods Of Use Thereof

View page
US Patent:
20160311903, Oct 27, 2016
Filed:
Mar 14, 2016
Appl. No.:
15/069622
Inventors:
- South San Francisco CA, US
Li Mei - San Francisco CA, US
Stephen James Moore - Danville CA, US
Margaret T.L. Nguyen - San Francisco CA, US
Daniel Robert Hostetter - Palo Alto CA, US
Olga Vasiljeva - Cupertino CA, US
Jason Gary Sagert - San Mateo CA, US
Jonathan Alexander Terrett - Cupertino CA, US
International Classification:
C07K 16/28
A61K 39/395
A61K 47/48
Abstract:
The invention relates generally to antibodies that bind programmed death ligand 1 (PDL1), activatable antibodies that specifically bind to PDL1 and methods of making and using these anti-PDL1 antibodies and anti-PDL1 activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.
Control profile
Li X Mei from San Francisco, CA, age ~72 Get Report